IDx Technologies announced that it has appointed former LabCorp executive Seth Rainford as President of Global Markets. In his newly created role, Mr. Rainford will be charged with expanding market opportunities and driving operational excellence at IDx.
“Seth has a proven track record of increasing market share and profitability for health systems and publicly traded companies,” Michael Abramoff, MD, PhD, founder and CEO of IDx, said in a company news release. “His breadth of experience will be a valuable asset as we work to accelerate our growing portfolio of customers. It is exciting to have him on board.”
Mr. Rainford joins the company during a rapid stage of growth, shortly after the company received a breakthrough FDA clearance for the first autonomous AI diagnostic system in any field of medicine. The AI system, called IDx-DR, is designed to detect diabetic retinopathy, a leading cause of blindness, in primary care without requiring an eye care specialist to interpret the results.
Mr. Rainford most recently served as Regional Vice President & General Manager of LabCorp in the Greater Chicago Area, leading a strategic transformation of the Midwest business unit. Previously, he served as Vice President at Northwestern Medicine, where he drove the commercialization and scaling of their outreach diagnostics business.